ow. It’s Friday. This week was particularly interminable, wasn’t it? This is Meghana, by the way, subbing in for Ed by way of The Readout. (Sign up here!) As we ready ourselves for the glorious weekend, here’s a roundup of some notable pharma news:

Chinese scientists have used CRISPR to correct genetic mutations in a human embryo, New Scientist reports. Though the study focused on just six human embryos, it’s showing that CRISPR seems to work better in normal embryos than it did in previous tests on abnormal embryos that couldn’t develop into children. In related news, US scientists have made some major strides in synthetically assembling a complete yeast genome, STAT’s Sharon Begley reports.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.